1
|
Ivanova ZG, Aleksiev TI, Dobrev HP. Onychomadesis in a COVID-19 patient. Wien Med Wochenschr 2023; 173:272-275. [PMID: 36441360 PMCID: PMC9703413 DOI: 10.1007/s10354-022-00988-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2022] [Accepted: 10/21/2022] [Indexed: 11/29/2022]
Abstract
We report the case of a 67-year-old woman who developed onychomadesis on 9 of her fingers 2 months after recovering from COVID-19, with subsequent full nail regrowth after 4 months. The development of onychomadesis in COVID-19 is probably related to inhibition of nail proliferation due to fever, direct viral damage, or an inflammatory process associated with endothelial damage and obliterative microangiopathy in the nail matrix area. Clinicians should be aware of nail changes and actively seek them out in patients with COVID-19.
Collapse
Affiliation(s)
- Zlatina Georgieva Ivanova
- Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002 Plovdiv, Bulgaria
| | - Teodor Ivanov Aleksiev
- Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002 Plovdiv, Bulgaria
| | - Hristo Petrov Dobrev
- Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002 Plovdiv, Bulgaria
| |
Collapse
|
2
|
Sil A, Ghosh S, Das A, Chandra A. Transverse erythronychia: A unique nail manifestation of COVID-19 infection and brief review of COVID-19 associated nail changes. J R Coll Physicians Edinb 2022; 52:320-323. [PMID: 36476144 PMCID: PMC9742509 DOI: 10.1177/14782715221142559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Over the past 2 years, a plethora of mucocutaneous manifestations have been described to be associated with coronavirus 2019 (COVID-19) infection. Nail changes attributed to COVID-19 have rarely been documented in the literature. We describe here a unique nail finding 'transverse erythronychia' due to COVID-19 and review the literature on the diverse nail pathology attributed to the disease.
Collapse
Affiliation(s)
- Abheek Sil
- Department of Dermatology, Venereology,
and Leprosy, RG Kar Medical College and Hospital, Kolkata, India
| | - Shouvik Ghosh
- Department of Dermatology, Venereology,
and Leprosy, KPC Medical College and Hospital, Kolkata, India
| | - Anupam Das
- Department of Dermatology, Venereology,
and Leprosy, KPC Medical College and Hospital, Kolkata, India
| | - Atanu Chandra
- Department of Internal Medicine, RG Kar
Medical College and Hospital, Kolkata, India
| |
Collapse
|
3
|
Caracterización de las manifestaciones cutáneas por infección de SARS-COV-2 en pacientes de América Latina. PIEL 2022. [PMCID: PMC8995250 DOI: 10.1016/j.piel.2022.02.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Introducción en 2019 surgió el SARS-CoV-2, causante de la pandemia por la COVID-19 que se extendió rápidamente alrededor del mundo; en casos graves, este puede desencadenar un síndrome de tormenta de citoquinas y conllevar a la muerte. Las manifestaciones cutáneas pueden asociarse a la expresión del receptor ACE2 en queratinocitos, estas se han descrito en la literatura de diversos países. La presente revisión busca documentar las presentaciones cutáneas que se han descrito en los pacientes con COVID-19 en América Latina. Metodología realizamos una búsqueda en 9 bases de datos de artículos en español, portugués e inglés, hasta el 10 de marzo del 2021, utilizando los términos: «Skin», «Cutaneous manifestations», «COVID 19», «SARS-CoV-2», asociándolos al nombre de los países latinoamericanos. Se obtuvieron los datos básicos de los pacientes incluidos, luego se creó una tabla en Microsoft Excel para analizar y comparar los datos. Resultados se identificaron 22 publicaciones de 9 países. Obtuvimos información de 92 pacientes, predominantemente de sexo femenino y edad promedio de 31,6 años. Fueron documentadas 99 lesiones dermatológicas, en orden de frecuencia correspondieron a erupciones cutáneas, habones, petequias-púrpura y pápulas. En 70 pacientes se describió el segmento corporal afectado, principalmente el tronco, los miembros inferiores y superiores. Encontramos 39 fotografías y 5 histopatologías. Los tratamientos más comunes fueron los corticoides, los antipalúdicos y el interferón recombinante. Conclusiones se observan diferencias en las manifestaciones cutáneas por la COVID-19, entre las publicaciones latinoamericanas en comparación a los demás países. Parece haber un patrón propio, donde predomina la erupción cutánea eritematosa con habones, mientras que la pseudo-perniosis fue menos representativa.
Collapse
|
4
|
Çoban K, Durusoy Ç. The Nail and Hair Findings Developing In Patients Treated For COVID-19 Infection Flourescence of Keratinized Tissues on Wood's Lamp In COVID-19 Disease. J Cosmet Dermatol 2022; 21:1788-1795. [PMID: 35174612 DOI: 10.1111/jocd.14855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2021] [Revised: 11/11/2021] [Accepted: 01/28/2022] [Indexed: 11/28/2022]
Abstract
The new severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is the causative agent of coronavirus 2019 (COVID-2019) disease. A wide variety of symptoms of the disease have been frequently reported in the literature in recent years. However, information on the findings in keratinized tissues is stil limited. Data on changes in keratinized tissues such as nails, teeth and hair and oral mucousa due to drugs used in the treatment of this disease are also extremely insufficient. With this study, it was aimed to evaluate the changes in the keratinized tissues of our patients with COVID-19, who are frequently encountered in the Ear Nose and Throat outpatient clinic. The study was carried out on patients who applied to Başkent University Ear Nose and Throat clinic. There were 3 groups. The first group consisted of patients diagnosed with COVID-19 and received relevant medical treatments, the second group included individuals who have never experienced COVID-19 infection but have been vaccinated against COVID-19, and the third group is the control group with normal healthy individuals who have never been diagnosed with COVID-19 infection and have not been vaccinated so far. With the Wood's lamp, fluorescent changes in nails, hair, tooth and the oral mucousa were recorded. A total of 124(75 females, 49 males) patients were included in the study. Positive Wood's finding was significantly higher in COVID-19 group(Group 1) who received Favipravir when compared to individuals who did not receive Favipravir (p<0,001). Wood's positivity was not detected in any of the individuals who did not use favipravir. The rate of determining Wood's positivity in favipravir users decreases after 58 days. The adverse effects of the accumulation of the drugs- mainly Favipravir- used in the treatment of COVID-19 disease, have not yet been clearly demonstrated so far. Revealing the findings in these tissues with this study will pave the way for investigating changes or drug sequestrations in other organs in the long term.
Collapse
Affiliation(s)
- Kübra Çoban
- Başkent University Medical Faculty, Otorhinolaryngology Department
| | - Çiçek Durusoy
- Başkent University Medical Faculty, Dermatology Department
| |
Collapse
|
5
|
Kammoun N, Kouki C, Hammami F, Sellami K, Rekik M, Bahloul E, Chtioui E, Amouri M, Masmoudi A, Turki H. The red half-moon nail sign: a new case report. J Cosmet Dermatol 2022; 21:5248-5249. [PMID: 35166013 DOI: 10.1111/jocd.14850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2021] [Revised: 01/27/2022] [Accepted: 01/31/2022] [Indexed: 11/29/2022]
Affiliation(s)
- N Kammoun
- Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia
| | - C Kouki
- Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia
| | - F Hammami
- Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia
| | - K Sellami
- Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia
| | - M Rekik
- Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia
| | - E Bahloul
- Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia
| | - E Chtioui
- Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia
| | - M Amouri
- Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia
| | - A Masmoudi
- Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia
| | - H Turki
- Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia
| |
Collapse
|
6
|
Toader M, Branisteanu D, Glod M, Esanu I, Branisteanu C, Capsa MS, Dimitriu A, Nicolescu A, Pinzariu A, Branisteanu D. Mucocutaneous lesions associated with SARS‑CoV‑2 infection (Review). Exp Ther Med 2022; 23:258. [PMID: 35251324 PMCID: PMC8892620 DOI: 10.3892/etm.2022.11183] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2021] [Accepted: 11/10/2021] [Indexed: 01/08/2023] Open
Abstract
The ongoing COVID-19 pandemic, declared by the World Health Organisation in March 2020, with the emergence of new, possibly more contagious and more virulent strains, remains a research subject, with the complex systemic involvement better described and understood, but also with a variety of skin and mucosal lesions described in the literature. Mucocutaneous lesions associated with SARS-CoV-2 infection are still under investigation, due to their polymorphic clinical aspect and incompletely understood pathogenic mechanism. The cutaneous inflammatory, exanthematous and purpuric rashes, erythemato-purpuric enanthems, oral ulcers, lichenoid oral lesions, conjunctivitis, conjunctival pseudomembranes, or corneal lesions have been described in patients with COVID-19. Several classifications have been proposed based on the clinical pattern, histological findings, and possible pathogenic mechanisms. The pathogenic mechanism, the diagnostic criteria, the prognostic importance of these lesions are still being debated. The diverse clinical aspects of dermatological manifestations render the diagnosis difficult. However, several clinical patterns strongly associated with COVID-19, such as chilblains, papulovesicular exanthems, and febrile rash require increased awareness and changes to the investigation protocols for these conditions, to include testing for SARS-CoV-2. In the present review, the mucocutaneous findings associated with the novel coronavirus infection, reported thus far in the literature, was provided.
Collapse
Affiliation(s)
- Mihaela Toader
- Department of Oral Dermatology, ‘Grigore T. Popa’ University of Medicine and Pharmacy, 700115 Iasi, Romania
| | - Daniel Branisteanu
- Department of Ophthalmology, ‘Grigore T. Popa’ University of Medicine and Pharmacy, 700115 Iasi, Romania
| | - Mihai Glod
- Department of Surgery, ‘Grigore T. Popa’ University of Medicine and Pharmacy, 700115 Iasi, Romania
| | - Irina Esanu
- Department of Internal Medicine, ‘Grigore T. Popa’ University of Medicine and Pharmacy, 700115 Iasi, Romania
| | | | - Maria-Stefana Capsa
- Department of Dermatology, ‘Railway Clinical Hospital’, 700506 Iasi, Romania
| | - Andreea Dimitriu
- Department of Dermatology, ‘Arcadia’ Hospitals and Medical Centers, 700620 Iasi, Romania
| | - Alin Nicolescu
- Department of Dermatology, Roma Medical Center for Diagnosis and Treatment, 011773 Bucharest, Romania
| | - Alin Pinzariu
- Department of Physiology, ‘Grigore T. Popa’ University of Medicine and Pharmacy, 700115 Iasi, Romania
| | - Daciana Branisteanu
- Department of Dermatology, ‘Grigore T. Popa’ University of Medicine and Pharmacy, 700115 Iasi, Romania
| |
Collapse
|
7
|
Tammaro A, Adebanjo GAR, Parisella FR, Luzi F, Scarabello A. The hair and nail manifestations of COVID-19. J Cosmet Dermatol 2022; 21:1339-1346. [PMID: 35032337 DOI: 10.1111/jocd.14774] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2021] [Revised: 11/12/2021] [Accepted: 01/10/2022] [Indexed: 11/29/2022]
Abstract
Emerging literature evidence shows that the manifestations of the coronavirus disease 2019 (COVID-19), which is the disease caused by SARS-CoV-2, encompass alterations of the pulmonary, cardiovascular, gastrointestinal and neurological system. Moreover, hematologic and dermatologic manifestations have been documented. The aim of this review is to summarize the dermatologic manifestations of COVID-19 involving the hair and nails in a narrative way. A total of 1136 patients have been reported to have de-novo hair loss following COVID-19. Notably, 958 patients experienced telogen effluvium (TE) (female/male ratio = 3,86:1), two female patients experienced anagen effluvium and 176 people had alopecia areata (female/male ratio of 19:3). Ten patients were reported to have ungual changes following the infection with the novel coronavirus: the individuals affected were 6 women and 4 men. COVID-19 can be associated to hair and ungual manifestations. This review summarizes the evidence regarding the hair and ungual manifestations of COVID-19, which could be harnessed to better understand the clinical implications and pathophysiology of this disease that has been burdening society globally since December 2019.
Collapse
Affiliation(s)
- Antonella Tammaro
- NESMOS Dermatology Department, Sapienza University of Rome, Rome, Italy
| | | | | | - Fabiola Luzi
- NESMOS Dermatology Department, Sapienza University of Rome, Rome, Italy
| | | |
Collapse
|
8
|
Aouali S, Sefraoui S, Zizi N, Dikhaye S. Half and half nail, is it a marker of severe COVID-19 infection? Ann Med Surg (Lond) 2021; 71:102963. [PMID: 34691452 PMCID: PMC8519785 DOI: 10.1016/j.amsu.2021.102963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2021] [Revised: 10/14/2021] [Accepted: 10/14/2021] [Indexed: 11/23/2022] Open
Abstract
Introduction Several cutaneous manifestations have been described during COVID-19 infection, however ungual signs remain neglected. Half and half nail or Lindsay nails is a rare clinical finding, frequently seen in chronic renal failure, and many other disorders. Case report We report 2 cases of half and half nail aspect occurring during severe COVID-19 infection, without a history of kidney disease, suggesting that ‘Lindsay Nails’ can be considered as a severity marker. Discussion An increasing number of nails changes has been reported since the COVID-19 outbreak. As well as the acral manifestations of COVID-19, the acute appearance of Half and half nail sign can be explained by a vascular involvement that may induce a transient matrix injury. Conclusion We report the first description of acute onset of half and half nails during COVID-19 severe infection in 2 patients without a history of kidney failure or any other condition previously described, suggesting that it can be considered as a severity marker. Half and half nail or Lindsay’s nail is a rare clinical finding that can be seen in many chronic diseases. Covid nails have been widely reported during the COVID 19 Outbreak. We report the 2 cases of half and half nail occuring during severe COVID-19 infection.
Collapse
Affiliation(s)
- Soraya Aouali
- Department of Dermatology, Mohammed the VI University Hospital of Oujda, Morocco
| | - Saida Sefraoui
- Department of Dermatology, Mohammed the VI University Hospital of Oujda, Morocco
| | - Nada Zizi
- Department of Dermatology, Mohammed the VI University Hospital of Oujda, Morocco.,Laboratory of Epidemiology, Clinical Research and Public Health, Faculty of Medicine and Pharmacy, Mohamed the First University of Oujda, Oujda, Morocco
| | - Siham Dikhaye
- Department of Dermatology, Mohammed the VI University Hospital of Oujda, Morocco.,Laboratory of Epidemiology, Clinical Research and Public Health, Faculty of Medicine and Pharmacy, Mohamed the First University of Oujda, Oujda, Morocco
| |
Collapse
|
9
|
Yanatma I, Cenk H. Evaluation of Nail Findings in Patients with COVID-19 History and Wood's Lamp Examination. Skin Appendage Disord 2021; 38:1-6. [PMID: 34934766 PMCID: PMC8678237 DOI: 10.1159/000518983] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2021] [Accepted: 08/06/2021] [Indexed: 12/03/2022] Open
Abstract
Introduction Various skin findings due to coronavirus have been identified. There are a few case reports on nail findings after coronavirus (COVID-19) infection. We aimed to document the nail findings of the COVID-19 survivors and shed light on the interesting luminescence seen under the Wood's light. Methods One hundred and seventy-four patients diagnosed with COVID-19 infection in the last 100 days were grouped in terms of the agents used in the treatment. Fifty-seven volunteers without a history of infection were included. Results Patients treated with favipiravir had a significantly higher positivity of luminescence (p: 0.0001). The most common nail findings in patients were splinter hemorrhage (13%), followed by leukonychia (12%) and longitudinal ridges (7.9%). Discussion/Conclusions The luminescence may be seen due to the accumulation of favipiravir or its excipients (titanium dioxide and yellow ferric oxide) on the nails. Wood's lamp examination of the plasma taken from a patient after favipiravir's first dose revealed the same luminescence as we saw on the nails. Accordingly, this accumulation may be seen in the vital organs. Although our knowledge about the virus increases day by day, the potentially hazardous effects of the virus and long-term complications of the treatment options are still being investigated.
Collapse
Affiliation(s)
- Irem Yanatma
- Department of Dermatology, Seydisehir State Hospital, Konya, Turkey
| | - Hulya Cenk
- Department of Dermatology, Pamukkale University, Denizli, Turkey
| |
Collapse
|
10
|
Farajzadeh S, Khalili M, Dehghani S, Babaie S, Fattah M, Abtahi-Naeini B. Top 10 acral skin manifestations associated with COVID-19: A scoping review. Dermatol Ther 2021; 34:e15157. [PMID: 34628708 PMCID: PMC8646918 DOI: 10.1111/dth.15157] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2021] [Revised: 10/06/2021] [Accepted: 10/07/2021] [Indexed: 12/29/2022]
Abstract
COVID‐19‐associated cutaneous manifestations are one of the most important and relatively common extra‐respiratory presentations of SARS‐COV‐2 infection. The exact identification and classification of these lesions can facilitate the accurate diagnosis and treatment. There are several case reports and small case series which describe cutaneous lesions in hands and feet. Currently, there is no scoping review about acral skin manifestations associated with COVID‐19. This paper covers the COVID‐related acral skin manifestations in 10 entities including acral papulo‐vesicular eruption, acral urticarial lesion, acral non‐inflammatory purpura and necrosis, acro‐ischemia associated COVID‐19, acral vasculitis, chilblain‐like lesion (COVID Toe), acral erythema multiform (EM) like lesion, hand and foot skin lesions associated with multisystem inflammatory syndrome in children (MISC), acral peeling conditions and red half‐moon nail sign. Future studies should focus on exact investigation of etiologies of these lesions including role of immune senescence, environment, gender, immunogenetics and relation of these lesion with major organ involvements.
Collapse
Affiliation(s)
- Saeedeh Farajzadeh
- Pediatric Dermatology Department, Kerman university of Medical Science, Kerman, Iran
| | - Maryam Khalili
- Pediatric Dermatology Department, Kerman university of Medical Science, Kerman, Iran
| | - Shakiba Dehghani
- School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Sharareh Babaie
- Department of Pediatric Intensive Care Unit, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.,Child Growth and Development Research Center, Research Institute for Primordial Prevention of Noncommunicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Mahdi Fattah
- Department of Dermatology, Sulaimani Center for Skin Disease Treatment, Sulaimani, Iraq
| | - Bahareh Abtahi-Naeini
- Pediatric Dermatology Division of Department of Pediatrics, Imam Hossein Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.,Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
| |
Collapse
|
11
|
Fernández-Lázaro D, Garrosa M. Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review. Viruses 2021; 13:1916. [PMID: 34696346 PMCID: PMC8540564 DOI: 10.3390/v13101916] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2021] [Revised: 09/12/2021] [Accepted: 09/20/2021] [Indexed: 01/08/2023] Open
Abstract
Coronavirus disease 2019 (COVID-19) is a multisystem disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), that primarily causes respiratory symptoms. However, an increasing number of cutaneous manifestations associated with this disease have been reported. The aim of this study is to analyze the scientific literature on cutaneous manifestations associated with SARS-CoV-2 by means of a narrative literature review until June 2021. The search was conducted in the following electronic databases: Medline (PubMed), SciELO, and Cochrane Library Plus. The most common cutaneous manifestations in patients with COVID-19 are vesicular eruptions, petechial/purpuric rashes, acral lesions, liveoid lesions, urticarial rash, and maculopapular-erythematous rash. These manifestations may be the first presenting symptoms of SARS-CoV-2 infection, as is the case with acral lesions, vesicular eruptions, and urticaria. In relation to severity, the presence of liveoid lesions may be associated with a more severe course of the disease. Treatment used for dermatological lesions includes therapy with anticoagulants, corticosteroids, and antihistamines. Knowledge of the dermatologic manifestations associated with SARS-CoV-2 contributes to the diagnosis of COVID-19 in patients with skin lesions associated with respiratory symptoms or in asymptomatic patients. In addition, understanding the dermatologic lesions associated with COVID-19 could be useful to establish a personalized care plan.
Collapse
Affiliation(s)
- Diego Fernández-Lázaro
- Department of Cellular Biology, Histology and Pharmacology, Faculty of Health Sciences, University of Valladolid, Campus of Soria, 42004 Soria, Spain
- Neurobiology Research Group, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain;
| | - Manuel Garrosa
- Neurobiology Research Group, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain;
- Area of Histology, Faculty of Medicine, Institute of Neurosciences of Castile and Leon (INCYL), University of Valladolid, 47005 Valladolid, Spain
| |
Collapse
|
12
|
Yin H, Wang S, Yu Y, Chen S, Lu L. Moving nail bands in systemic lupus erythematosus. J Eur Acad Dermatol Venereol 2021; 36:e130-e132. [PMID: 34553792 DOI: 10.1111/jdv.17695] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2021] [Accepted: 09/15/2021] [Indexed: 11/29/2022]
Affiliation(s)
- H Yin
- Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - S Wang
- Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Y Yu
- Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - S Chen
- Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - L Lu
- Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| |
Collapse
|
13
|
Preda-Naumescu A, Penney K, Pearlman RL, Brodell RT, Daniel CR, Nahar VK. Nail Manifestations in COVID-19: Insight into a Systemic Viral Disease. Skin Appendage Disord 2021; 183:1-6. [PMID: 34580633 PMCID: PMC8450840 DOI: 10.1159/000518087] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2021] [Accepted: 06/21/2021] [Indexed: 11/21/2022] Open
Abstract
Nail manifestations are 1 of the several extrapulmonary findings associated with COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Nail changes, however, have been largely ignored and not yet summarized. This article is intended to increase awareness of nail manifestations of SARS-CoV-2, which occur weeks to months after acute infection and the periungual pernio-like changes may occur concomitantly with infection. An electronic search was carried out in PubMed (Medline), Science Direct, and Scopus databases. The following keywords and all of their possible combinations were used to identify studies: “SARS-CoV-2,” “COVID-19,” “Coronavirus,” “2019-ncov,” “nail,” and “nails.” Six case reports were included in this study. Manifestations identified included red half-moon sign, transverse orange nail lesions, Mees' lines, and Beau's lines. Though largely nonspecific, these findings can be recognized with the onset of symptom onset or as late as 16 weeks following the disease. Some of these findings are shared with other conditions associated with a proinflammatory state. Nail changes offer unique insight into the pathophysiologic basis for SARS-CoV-2 and they may serve as diagnostic clues.
Collapse
Affiliation(s)
- Ana Preda-Naumescu
- University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA
| | - Kayla Penney
- LSU Health Shreveport School of Medicine, Shreveport, Louisiana, USA
| | - Ross L Pearlman
- University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA
| | - Robert T Brodell
- University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA
| | - Carlton Ralph Daniel
- Department of Dermatology, School of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA
| | - Vinayak K Nahar
- University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.,Department of Preventive Medicine, School of Medicine/John D. Bower School of Population Health, University of Mississippi Medical Center, Jackson, Mississippi, USA
| |
Collapse
|
14
|
Wollina U, Kanitakis J, Baran R. Nails and COVID-19 - A comprehensive review of clinical findings and treatment. Dermatol Ther 2021; 34:e15100. [PMID: 34398500 PMCID: PMC8420555 DOI: 10.1111/dth.15100] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2021] [Revised: 08/01/2021] [Accepted: 08/13/2021] [Indexed: 12/19/2022]
Abstract
The SARS‐CoV‐2 infection, responsible for COVID‐19, has raised the interest for infection‐associated muco‐cutaneous symptoms. While dermatologic symptoms in general gained an increasing awareness, affection of the nail organ has been mentioned only recently. We provide a narrative review on COVID‐19 manifestation on the nail organ and add symptoms induced by personal protective measures and SARS‐CoV‐2 vaccination. Available treatment options are discussed.
Collapse
Affiliation(s)
- Uwe Wollina
- Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Dresden, Germany
| | - Jean Kanitakis
- Dermatology Department, Edouard Herriot Hospital Group, (Pav. R), Hospices Civils de Lyon, Lyon, France
| | - Robert Baran
- Dermatology, Nail Disease Center, Cannes, France
| |
Collapse
|
15
|
Hadeler E, Morrison BW, Tosti A. A review of nail findings associated with COVID-19 infection. J Eur Acad Dermatol Venereol 2021; 35:e699-e709. [PMID: 34131957 PMCID: PMC8447455 DOI: 10.1111/jdv.17448] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2021] [Revised: 05/20/2021] [Accepted: 06/10/2021] [Indexed: 01/08/2023]
Affiliation(s)
- E Hadeler
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA
| | - B W Morrison
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA
| | - A Tosti
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA
| |
Collapse
|
16
|
Akl J, El-Kehdy J, Salloum A, Benedetto A, Karam P. Skin disorders associated with the COVID-19 pandemic: A review. J Cosmet Dermatol 2021; 20:3105-3115. [PMID: 34077629 PMCID: PMC8242622 DOI: 10.1111/jocd.14266] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2021] [Accepted: 05/26/2021] [Indexed: 12/16/2022]
Abstract
Introduction In December 2019, a new coronavirus has emerged out of China, the SARS‐CoV‐2 virus, causing a disease known as COVID‐19, which steadily has progressed into a pandemic. This coronavirus affects many organs, including the skin, whose manifestations are a consequence of the disease itself, as well as the preventative measures taken to avoid the infection. This paper reviews the cutaneous manifestations which currently have been encountered during this pandemic. Methods A search was conducted on PubMed, and all relevant articles were included. Results The results show the occurrence of many cutaneous findings, ranging from those related to the infection itself and to various dermatitides related to the use of personal protective equipment (PPE) utilized by healthcare workers while attending to infected patients. Discussion Recognizing these findings is important for the accurate diagnosis of those infected with COVID‐19 as well as the prompt treatment of the side effects caused by PPE that might further impair the effectiveness of healthcare workers.
Collapse
Affiliation(s)
- Jennifer Akl
- Department of Dermatology, Saint George Hospital University Medical Center, Beirut, Lebanon.,Faculty of Medicine, University of Balamand, Beirut, Lebanon
| | - Jessica El-Kehdy
- Department of Dermatology, Saint George Hospital University Medical Center, Beirut, Lebanon.,Faculty of Medicine, University of Balamand, Beirut, Lebanon
| | - Antoine Salloum
- Department of Dermatology, Saint George Hospital University Medical Center, Beirut, Lebanon.,Faculty of Medicine, University of Balamand, Beirut, Lebanon.,Dermatologic SurgiCenter, Philadelphia, PA, USA
| | - Anthony Benedetto
- Dermatologic SurgiCenter, Philadelphia, PA, USA.,Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Paula Karam
- Department of Dermatology, Saint George Hospital University Medical Center, Beirut, Lebanon.,Faculty of Medicine, University of Balamand, Beirut, Lebanon
| |
Collapse
|
17
|
Gülseren D, Yalıcı-Armagan B. Yellow-white fluorescence on the nails: A novel finding of Favipiravir used for the treatment of COVID-19. J Cosmet Dermatol 2021; 20:2392-2393. [PMID: 33978291 PMCID: PMC8242614 DOI: 10.1111/jocd.14214] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 04/21/2021] [Accepted: 04/28/2021] [Indexed: 11/30/2022]
Affiliation(s)
- Duygu Gülseren
- Department of Dermatology, School of Medicine, Hacettepe University, Ankara, Turkey
| | - Başak Yalıcı-Armagan
- Department of Dermatology, School of Medicine, Hacettepe University, Ankara, Turkey
| |
Collapse
|
18
|
Demir B, Yuksel EI, Cicek D, Turkoglu S. Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19. J Eur Acad Dermatol Venereol 2021; 35:e551-e553. [PMID: 33987893 PMCID: PMC8242612 DOI: 10.1111/jdv.17347] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- B Demir
- Department of Dermatology, Firat University Hospital, Elazig, Turkey
| | - E I Yuksel
- Department of Dermatology, Firat University Hospital, Elazig, Turkey
| | - D Cicek
- Department of Dermatology, Firat University Hospital, Elazig, Turkey
| | - S Turkoglu
- Department of Dermatology, Firat University Hospital, Elazig, Turkey
| |
Collapse
|
19
|
Ocampo-Garza SS, Ocampo-Candiani J, Camela E, Vastarella M, Fabbrocini G, Scalvenzi M, Villani A. Nail changes as manifestation of systemic disease in COVID-19 infection. J Eur Acad Dermatol Venereol 2021; 35:e474-e475. [PMID: 33830556 PMCID: PMC8251398 DOI: 10.1111/jdv.17273] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2021] [Accepted: 03/22/2021] [Indexed: 12/17/2022]
Affiliation(s)
- S S Ocampo-Garza
- Departamento de Dermatología, Universidad Autónoma de Nuevo León, Hospital Universitario ¨Dr. José Eleuterio González¨, Monterrey, Nuevo León, México.,Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - J Ocampo-Candiani
- Departamento de Dermatología, Universidad Autónoma de Nuevo León, Hospital Universitario ¨Dr. José Eleuterio González¨, Monterrey, Nuevo León, México
| | - E Camela
- Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - M Vastarella
- Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - G Fabbrocini
- Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - M Scalvenzi
- Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - A Villani
- Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| |
Collapse
|
20
|
Lavery MJ, Bouvier CA, Thompson B. Cutaneous manifestations of COVID-19 in children (and adults): A virus that does not discriminate. Clin Dermatol 2021; 39:323-328. [PMID: 34272030 PMCID: PMC7604214 DOI: 10.1016/j.clindermatol.2020.10.020] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a beta coronavirus with a characteristic S-glycoprotein spike on the cell surface. Initial reports did not include cutaneous manifestations as a feature of COVID-19; however, there is a growing repertoire of reports demonstrating an array of dermatologic manifestations on the skin in children and adults. Dermatologic afflictions have been summarized into different categories several times, with the most recent analysis identifying six clinical patterns: urticaria, maculopapular-morbilliform eruption, papulovesicular exanthem, chilblain-like acral pattern, livedo reticularis-livedo racemosa pattern, and purpuric vasculitic pattern. In children, the dermatologic features appear to occur before or concomitantly with other COVID-19 manifestations. Dermatologists play a key role in diagnosing patients with COVID-19 who may present for the first time unwittingly exhibiting early signs of COVID-19. We have reviewed the current evidence on the dermatologic impact of COVID-19 in both the adult and pediatric populations.
Collapse
Affiliation(s)
- Michael Joseph Lavery
- Department of Dermatology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom; Department of Dermatology, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom.
| | - Charles Alexis Bouvier
- Department of Pediatrics, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom
| | - Ben Thompson
- Department of Dermatology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom; Department of Dermatology, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom
| |
Collapse
|
21
|
Grover C, Gaurav V. ”COVID” terminology in dermatology. Indian J Dermatol 2021; 66:705. [PMID: 35283498 PMCID: PMC8906297 DOI: 10.4103/ijd.ijd_472_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Ever since the beginning of COVID-19 pandemic, mucocutaneous manifestations started being noticed and are still being documented. Many of these have been described with the prefix “COVID” and may occur due to the infection (e.g., COVID rash), use of personal protective equipment in healthcare workers (e.g., COVID hand dermatitis) or extensive use of novel vaccines (e.g., COVID arm). This article attempts to summarize such entities with clinical relevance to dermatologists and physicians in general and to create awareness about this fast-evolving COVID lexicon.
Collapse
|
22
|
Tammaro A, Adebanjo GAR, Erasmus HP, Chello C, Pezzuto A, Ramirez-Estrada S, Rello J. Transverse orange nail lesions following SARS-CoV-2 infection. Dermatol Ther 2020; 34:e14688. [PMID: 33340203 PMCID: PMC7883228 DOI: 10.1111/dth.14688] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2020] [Revised: 12/10/2020] [Accepted: 12/16/2020] [Indexed: 01/10/2023]
Affiliation(s)
- Antonella Tammaro
- NESMOS, Dermatology Department, Sapienza University of Rome, Rome, Italy
| | | | - Hans-Peter Erasmus
- Department of Internal Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany
| | - Camilla Chello
- NESMOS, Dermatology Department, Sapienza University of Rome, Rome, Italy
| | - Aldo Pezzuto
- Department of Cardiovascular-Respiratory Science, Sant'Andrea Hospital-Sapienza University of Rome, Rome, Italy
| | | | - Jordi Rello
- Centro de Investigación Biomedica en Red de Enfermedades Respirorias (CIBERES), Instituto Salud Carlos III, Madrid, Spain.,Clinical Research/Epidemiology in Pneumonia and Sepsis (CRIPS), Vall d'Hebron Institut of Research (VHIR), Barcelona, Spain.,Clinical Research, CHU Nîmes, Université Montpellier-Nimes, Nîmes, France
| |
Collapse
|